Ajit Rayamajhi1, Anupama Thapa2, Manoj Kumar3, Catherine Yen4, Jacqueline E Tate4, Umesh D Parashar4, Anjana Karki Rayamajhi5. 1. Janak Medical and Research Center, Balaju, Kathmandu, Nepal; Kanti Children's Hospital, Maharajgunj, Kathmandu, Nepal; National Academy of Medical Sciences, Kathmandu, Nepal. Electronic address: ajitrnp@yahoo.com. 2. Janak Medical and Research Center, Balaju, Kathmandu, Nepal; Kanti Children's Hospital, Maharajgunj, Kathmandu, Nepal. 3. Department of Pediatrics, University of Alberta, Edmonton, Canada. 4. Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Janak Medical and Research Center, Balaju, Kathmandu, Nepal; B & B Hospital, Gwarko, Lalitpur, Nepal.
Abstract
BACKGROUND: Rotavirus is the most common cause of severe diarrhea in Nepali children, accounting for 25-33% of childhood diarrhea hospitalizations. Two rotavirus vaccines recommended for inclusion in national immunization programs have been associated with a low risk of intussusception in post-marketing studies conducted in several countries. Data on the epidemiology of intussusception hospitalizations are lacking in Nepal. Thus, we aimed to describe the epidemiology of intussusception-associated hospitalizations among Nepali children in preparation for rotavirus vaccine introduction. METHODS: A retrospective review of intussusception hospitalizations for a three year period was conducted at two major pediatric hospitals in Kathmandu, Nepal. Possible intussusception cases were identified through admission, discharge, and operation theater logs and ultrasound registers. Cases with a diagnosis of possible intussusception were selected for medical record review and classified as confirmed if they met the Brighton Collaboration level 1 criteria of diagnostic certainty and the child was aged < 24 months. Data on demographics, clinical course, and outcome were abstracted and analyzed. RESULTS: Eight-five confirmed intussusception cases were identified; most (96%) were confirmed at surgery. The number of intussusception cases peaked between ages 4-7 months; no cases occurred in children 0-2 months. Fifty-nine (64%) case-patients were male. The median duration of symptoms before admission was 2 days (range: 0-14). Abdominal pain, bloody stool, and vomiting were the most common clinical features. All cases underwent surgical treatment; there was only one death. CONCLUSIONS: This is the first study to evaluate the epidemiology of intussusception hospitalizations among children aged < 24 months in Nepal. Because the public health impact of rotavirus vaccination could be substantial in Nepal, where childhood diarrhea-related morbidity and mortality are high, this baseline knowledge of intussusception prior to introduction of rotavirus vaccine in the national immunization schedule will provide useful information for post-vaccine introduction safety monitoring.
BACKGROUND: Rotavirus is the most common cause of severe diarrhea in Nepali children, accounting for 25-33% of childhood diarrhea hospitalizations. Two rotavirus vaccines recommended for inclusion in national immunization programs have been associated with a low risk of intussusception in post-marketing studies conducted in several countries. Data on the epidemiology of intussusception hospitalizations are lacking in Nepal. Thus, we aimed to describe the epidemiology of intussusception-associated hospitalizations among Nepali children in preparation for rotavirus vaccine introduction. METHODS: A retrospective review of intussusception hospitalizations for a three year period was conducted at two major pediatric hospitals in Kathmandu, Nepal. Possible intussusception cases were identified through admission, discharge, and operation theater logs and ultrasound registers. Cases with a diagnosis of possible intussusception were selected for medical record review and classified as confirmed if they met the Brighton Collaboration level 1 criteria of diagnostic certainty and the child was aged < 24 months. Data on demographics, clinical course, and outcome were abstracted and analyzed. RESULTS: Eight-five confirmed intussusception cases were identified; most (96%) were confirmed at surgery. The number of intussusception cases peaked between ages 4-7 months; no cases occurred in children 0-2 months. Fifty-nine (64%) case-patients were male. The median duration of symptoms before admission was 2 days (range: 0-14). Abdominal pain, bloody stool, and vomiting were the most common clinical features. All cases underwent surgical treatment; there was only one death. CONCLUSIONS: This is the first study to evaluate the epidemiology of intussusception hospitalizations among children aged < 24 months in Nepal. Because the public health impact of rotavirus vaccination could be substantial in Nepal, where childhood diarrhea-related morbidity and mortality are high, this baseline knowledge of intussusception prior to introduction of rotavirus vaccine in the national immunization schedule will provide useful information for post-vaccine introduction safety monitoring.
Authors: F Raúl Velázquez; Romulo E Colindres; Concepción Grajales; M Teresa Hernández; María Guadalupe Mercadillo; F Javier Torres; MariaYolanda Cervantes-Apolinar; Rodrigo DeAntonio-Suarez; Eduardo Ortega-Barria; Maxim Blum; Thomas Breuer; Thomas Verstraeten Journal: Pediatr Infect Dis J Date: 2012-07 Impact factor: 2.129
Authors: Guillermo M Ruiz-Palacios; Irene Pérez-Schael; F Raúl Velázquez; Hector Abate; Thomas Breuer; SueAnn Costa Clemens; Brigitte Cheuvart; Felix Espinoza; Paul Gillard; Bruce L Innis; Yolanda Cervantes; Alexandre C Linhares; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Vesta Richardson; Doris Maribel Rivera-Medina; Luis Rivera; Belén Salinas; Noris Pavía-Ruz; Jorge Salmerón; Ricardo Rüttimann; Juan Carlos Tinoco; Pilar Rubio; Ernesto Nuñez; M Lourdes Guerrero; Juan Pablo Yarzábal; Silvia Damaso; Nadia Tornieporth; Xavier Sáez-Llorens; Rodrigo F Vergara; Timo Vesikari; Alain Bouckenooghe; Ralf Clemens; Béatrice De Vos; Miguel O'Ryan Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245
Authors: J P Buttery; M H Danchin; K J Lee; J B Carlin; P B McIntyre; E J Elliott; R Booy; J E Bines Journal: Vaccine Date: 2011-04-05 Impact factor: 3.641
Authors: Manish M Patel; Vesta Richardson López-Collada; Marília Mattos Bulhões; Lucia Helena De Oliveira; Aurora Bautista Márquez; Brendan Flannery; Marcelino Esparza-Aguilar; Ernesto Isaac Montenegro Renoiner; María Edilia Luna-Cruz; Helena Keico Sato; Luz del Carmen Hernández-Hernández; Gerardo Toledo-Cortina; Magdalena Cerón-Rodríguez; Neydi Osnaya-Romero; Mario Martínez-Alcazar; Rocío Gabriela Aguinaga-Villasenor; Arturo Plascencia-Hernández; Francisco Fojaco-González; Guillermo Hernández-Peredo Rezk; Sixto Fortino Gutierrez-Ramírez; Roberto Dorame-Castillo; Rogelio Tinajero-Pizano; Bernice Mercado-Villegas; Marilia Reichelt Barbosa; Eliane Mara Cesário Maluf; Lucimar Bozza Ferreira; Francisca Maria de Carvalho; Ana Rosa dos Santos; Eduardo Dolabella Cesar; Maria Elisa Paula de Oliveira; Carmem Lúcia Osterno Silva; Maria de Los Angeles Cortes; Cuauhtemoc Ruiz Matus; Jacqueline Tate; Paul Gargiullo; Umesh D Parashar Journal: N Engl J Med Date: 2011-06-16 Impact factor: 91.245
Authors: Chan Lee Giak; H S S Amar Singh; Revathy Nallusamy; Teoh Yee Leong; Timothy L Ng; Hans L Bock Journal: Southeast Asian J Trop Med Public Health Date: 2008-09 Impact factor: 0.267
Authors: John B Carlin; Kristine K Macartney; Katherine J Lee; Helen E Quinn; Jim Buttery; Ruth Lopert; Julie Bines; Peter B McIntyre Journal: Clin Infect Dis Date: 2013-08-26 Impact factor: 9.079
Authors: Lan Anh T Tran; Lay Myint Yoshida; Toyoko Nakagomi; Punita Gauchan; Koya Ariyoshi; Dang Duc Anh; Osamu Nakagomi; Vu Dinh Thiem Journal: Trop Med Health Date: 2013-08-20
Authors: Lamiya Samad; Mario Cortina-Borja; Haitham El Bashir; Alastair G Sutcliffe; Sean Marven; J Claire Cameron; Richard Lynn; Brent Taylor Journal: Vaccine Date: 2013-07-17 Impact factor: 3.641